Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes

MC Petrie, S Verma, KF Docherty, SE Inzucchi, I Anand… - Jama, 2020 - jamanetwork.com
Importance Additional treatments are needed for heart failure with reduced ejection fraction
(HFrEF). Sodium-glucose cotransporter 2 (SGLT2) inhibitors may be an effective treatment …
被引用次数：477 相关文章

[引用][C] Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

MC Petrie, S Verma, KF Docherty… - Jama-journal of the …, 2020 - repositorio.usp.br
ReP USP - Detalhe do registro: Effect of Dapagliflozin on Worsening Heart Failure and
Cardiovascular Death in Patients With Heart Failure With and Without Diabetes Home …

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

MC Petrie, S Verma, KF Docherty… - JAMA-JOURNAL OF …, 2020 - research.rug.nl
Importance: Additional treatments are needed for heart failure with reduced ejection fraction
(HFrEF). Sodium-glucose cotransporter 2 (SGLT2) inhibitors may be an effective treatment …

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.

MC Petrie, S Verma, KF Docherty, SE Inzucchi, I Anand… - JAMA, 2020 - europepmc.org
Results Among 4744 patients randomized (mean age, 66 years; 1109 [23%] women; 2605
[55%] without diabetes), 4742 completed the trial. Among participants without diabetes, the …

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

MC Petrie, S Verma, KF Docherty, SE Inzucchi… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Importance Additional treatments are needed for heart failure with reduced ejection fraction
(HFrEF). Sodium-glucose cotransporter 2 (SGLT2) inhibitors may be an effective treatment …
[HTML] nih.gov

[HTML][HTML] Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

MC Petrie, S Verma, KF Docherty, SE Inzucchi, I Anand… - JAMA, 2020 - ncbi.nlm.nih.gov
Results Among 4744 patients randomized (mean age, 66 years; 1109 [23%] women; 2605
[55%] without diabetes), 4742 completed the trial. Among participants without diabetes, the …

[引用][C] Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

MC Petrie, S Verma, KF Docherty, SE Inzucchi, I Anand… - JAMA, 2020 - cir.nii.ac.jp
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With
Heart Failure With and Without Diabetes | CiNii Research CiNii 国立情報学研究所 学術情報 …
[HTML] regionh.dk

[HTML][HTML] Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

MC Petrie, S Verma, KF Docherty… - JAMA-Journal of the …, 2020 - research.regionh.dk
Importance: Additional treatments are needed for heart failure with reduced ejection fraction
(HFrEF). Sodium-glucose cotransporter 2 (SGLT2) inhibitors may be an effective treatment …

Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes

MC Petrie, S Verma, KF Docherty… - JAMA: Journal of the …, 2020 - eprints.gla.ac.uk
Importance: Additional treatments are needed for heart failure with reduced ejection fraction
(HFrEF). Sodium-glucose cotransporter 2 (SGLT2) inhibitors may be an effective treatment …

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients with Heart Failure with and Without Diabetes

MC Petrie, KF Docherty, PS Jhund, JJV McMurray… - JAMA - openrepository.ru
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients
with Heart Failure with and Without Diabetes - «Национальный агрегатор открытых …